World Journal of
Pharmaceutical and Life Sciences

A REVIEW ON VACCINE SAFETY SURVEILLANCE IN PHARMACOVIGILANCE

Sravanthi Gandu, *Kumaraswamy Gandla, Kavitha Pingili and Julluru Bhasker

ABSTRACT

COVID-19 vaccines are the most important tool to stem the pandemic. They are being developed with unprecedented global collaboration and accelerated timelines to achieve regulatory pathways through national regulatory authorities, alongside preparations to ensure equitable access to the vaccines among people globally, preparations must be made within countries for COVID-19 vaccines safety surveillance on an urgent basis. Safety surveillance must be capable of investigating adverse events of special interest (AESI) and adverse events following immunization to determine a change in the benefit-risk profile of the vaccine, and to be able to anticipate coincidental events that might be attributed to the vaccine.

[Full Text Article]   [Download Certificate]